BioCentury | Jul 25, 2020
Management Tracks

New CFOs for Generation Bio, IQVia; plus changes at Gracell, AskBio, Replimune, Triplet, Twist, Cellectis, Verrica and more

...of Mustang Bio Inc. (NASDAQ:MBIO); Xie was president of the Fosun Healthcare Holdings unit of Fosun International...
BioCentury | Apr 6, 2019
Politics & Policy

CFIUS drawing line in sand on personal data

...source cited a November 2015 acquisition of insurance company Ironshore Inc. (New York, N.Y.) by Fosun International...
BioCentury | Dec 21, 2018
Financial News

Shanghai Henlius up for Hong Kong IPO

...Jiang was an associate director at Catalyst Biosciences Inc. (NASDAQ:CBIO). Shanghai Henlius' substantial shareholders include Fosun International...
BioCentury | Dec 15, 2018
Financial News

Shanghai Henlius up for Hong Kong IPO

...Jiang was an associate director at Catalyst Biosciences Inc. (NASDAQ:CBIO). Shanghai Henlius' substantial shareholders include Fosun International...
BioCentury | Oct 5, 2018
Finance

Fruitful partnerships

...entered four strategic partnerships with Takeda Ventures, UCB S.A. (Euronext:UCB), Ipsen Group (Euronext:IPN; Pink:IPSEY) and Fosun International...
BioCentury | Aug 17, 2018
Finance

Vaccine volatility

...from its Wednesday close and WuXi Biologics Inc. (HKEX:2269), which lost HK$11.60 (16%) to HK$62.50. Fosun International...
BioCentury | Aug 16, 2018
Politics & Policy

Innovative drugs reformer Bi out amid China vaccines scandal

...lost HK$5.65 on Thursday and is off HK$13.90 (17%) to HK$68.45 over the same period. Fosun International...
BioCentury | Aug 13, 2018
Company News

Management tracks: FDA, Allergan

...Biologic Products Holdings Inc. (NASDAQ:CBPO) hired Bing Li as CEO. He was managing director at Fosun International...
BioCentury | Aug 3, 2018
Politics & Policy

Safety, trade concerns weigh on China biotechs

...down HK$1.33 (15%) to HK$7.31; WuXi Biologics Inc. (HKSE:2269), off HK$11.75 (14%) to HK$73.70; and Fosun International...
BioCentury | May 18, 2018
Finance

China comes to Europe

...therapy Strimvelis. GSK received a 19.9% stake in the biotech in return. For Chinese pharma Fosun International...
...Euronext:ALCLS; NASDAQ:CLLS), Paris, France Crescendo Biologics Ltd., Cambridge, U.K. Elpiscience Biopharmaceuticals Co. Ltd., Shanghai, China Fosun International...
Items per page:
1 - 10 of 19
BioCentury | Jul 25, 2020
Management Tracks

New CFOs for Generation Bio, IQVia; plus changes at Gracell, AskBio, Replimune, Triplet, Twist, Cellectis, Verrica and more

...of Mustang Bio Inc. (NASDAQ:MBIO); Xie was president of the Fosun Healthcare Holdings unit of Fosun International...
BioCentury | Apr 6, 2019
Politics & Policy

CFIUS drawing line in sand on personal data

...source cited a November 2015 acquisition of insurance company Ironshore Inc. (New York, N.Y.) by Fosun International...
BioCentury | Dec 21, 2018
Financial News

Shanghai Henlius up for Hong Kong IPO

...Jiang was an associate director at Catalyst Biosciences Inc. (NASDAQ:CBIO). Shanghai Henlius' substantial shareholders include Fosun International...
BioCentury | Dec 15, 2018
Financial News

Shanghai Henlius up for Hong Kong IPO

...Jiang was an associate director at Catalyst Biosciences Inc. (NASDAQ:CBIO). Shanghai Henlius' substantial shareholders include Fosun International...
BioCentury | Oct 5, 2018
Finance

Fruitful partnerships

...entered four strategic partnerships with Takeda Ventures, UCB S.A. (Euronext:UCB), Ipsen Group (Euronext:IPN; Pink:IPSEY) and Fosun International...
BioCentury | Aug 17, 2018
Finance

Vaccine volatility

...from its Wednesday close and WuXi Biologics Inc. (HKEX:2269), which lost HK$11.60 (16%) to HK$62.50. Fosun International...
BioCentury | Aug 16, 2018
Politics & Policy

Innovative drugs reformer Bi out amid China vaccines scandal

...lost HK$5.65 on Thursday and is off HK$13.90 (17%) to HK$68.45 over the same period. Fosun International...
BioCentury | Aug 13, 2018
Company News

Management tracks: FDA, Allergan

...Biologic Products Holdings Inc. (NASDAQ:CBPO) hired Bing Li as CEO. He was managing director at Fosun International...
BioCentury | Aug 3, 2018
Politics & Policy

Safety, trade concerns weigh on China biotechs

...down HK$1.33 (15%) to HK$7.31; WuXi Biologics Inc. (HKSE:2269), off HK$11.75 (14%) to HK$73.70; and Fosun International...
BioCentury | May 18, 2018
Finance

China comes to Europe

...therapy Strimvelis. GSK received a 19.9% stake in the biotech in return. For Chinese pharma Fosun International...
...Euronext:ALCLS; NASDAQ:CLLS), Paris, France Crescendo Biologics Ltd., Cambridge, U.K. Elpiscience Biopharmaceuticals Co. Ltd., Shanghai, China Fosun International...
Items per page:
1 - 10 of 19